ATE355286T1 - Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel - Google Patents
Verfahren zur herstellung von pioglitazone als antidiabetisches mitttelInfo
- Publication number
- ATE355286T1 ATE355286T1 AT02734989T AT02734989T ATE355286T1 AT E355286 T1 ATE355286 T1 AT E355286T1 AT 02734989 T AT02734989 T AT 02734989T AT 02734989 T AT02734989 T AT 02734989T AT E355286 T1 ATE355286 T1 AT E355286T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- formula
- group
- residue
- general formula
- Prior art date
Links
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 title abstract 4
- 239000003472 antidiabetic agent Substances 0.000 title abstract 2
- 229960005095 pioglitazone Drugs 0.000 title abstract 2
- 229940125708 antidiabetic agent Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 abstract 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical group 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 239000002585 base Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 150000002466 imines Chemical class 0.000 abstract 1
- 125000002560 nitrile group Chemical group 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 abstract 1
- 229940031826 phenolate Drugs 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ20011501A CZ20011501A3 (cs) | 2001-04-26 | 2001-04-26 | Způsob výroby meziproduktu pro výrobu antidiabetika |
| CZ20011502A CZ20011502A3 (cs) | 2001-04-26 | 2001-04-26 | Způsob výroby antidiabetika |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE355286T1 true ATE355286T1 (de) | 2006-03-15 |
Family
ID=25746959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02734989T ATE355286T1 (de) | 2001-04-26 | 2002-04-25 | Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7009057B2 (de) |
| EP (1) | EP1387843B1 (de) |
| AT (1) | ATE355286T1 (de) |
| AU (1) | AU2002311057A1 (de) |
| DE (1) | DE60218449D1 (de) |
| EE (1) | EE200300519A (de) |
| HU (1) | HUP0400091A2 (de) |
| PL (1) | PL363738A1 (de) |
| RU (1) | RU2281285C2 (de) |
| SK (1) | SK14452003A3 (de) |
| WO (1) | WO2002088120A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004007490A2 (en) * | 2002-07-16 | 2004-01-22 | Cadila Healthcare Limited | A process to prepare pioglitazone via several intermediates. |
| US8993773B2 (en) | 2002-07-16 | 2015-03-31 | Cadila Healthcare Limited | Process to prepare pioglitazone via several novel intermediates |
| WO2004108721A1 (en) * | 2003-04-01 | 2004-12-16 | Sun Pharmaceutical Industries Limited | Process for the preparation of 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl] methyl]-2,4-thiazolidinedione |
| ES2219180B1 (es) * | 2003-05-09 | 2006-03-01 | Medichem, S.A. | Compuesto intermedio util para la preparacion de pioglitazona. |
| WO2004101560A1 (en) * | 2003-05-13 | 2004-11-25 | Synthon B.V. | Processes for making thiazolidinedione derivatives and compounds thereof |
| US7230016B2 (en) | 2003-05-13 | 2007-06-12 | Synthon Ip Inc. | Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same |
| US20070078170A1 (en) * | 2003-08-28 | 2007-04-05 | Khanduri Chandra H | Process for the preparation of pioglitazone |
| CN1319956C (zh) * | 2003-09-12 | 2007-06-06 | 深圳市海粤门生物科技开发有限公司 | 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用 |
| WO2005080387A2 (en) | 2004-02-20 | 2005-09-01 | Synthon B.V. | Processes for making pioglitazone and compounds of the processes |
| US7402713B2 (en) * | 2006-03-07 | 2008-07-22 | E.I. Du Pont De Nemours And Company | Processes for conversion of tyrosine to p-hydroxystyrene and p-acetoxystyrene |
| NZ571870A (en) | 2006-03-16 | 2011-07-29 | Metabolic Solutions Dev Co | Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids |
| PL2001468T3 (pl) | 2006-03-16 | 2013-03-29 | Metabolic Solutions Dev Co Llc | Analogi tiazolidynodionu |
| KR100791400B1 (ko) | 2006-09-06 | 2008-01-07 | 동우신테크 주식회사 | 티아졸리딘디온 유도체의 제조방법 |
| KR101537830B1 (ko) | 2007-09-14 | 2015-07-17 | 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 | 고혈압 치료용 티아졸리딘디온 유사체 |
| US8304441B2 (en) | 2007-09-14 | 2012-11-06 | Metabolic Solutions Development Company, Llc | Thiazolidinedione analogues for the treatment of metabolic diseases |
| WO2009148195A1 (en) * | 2008-06-02 | 2009-12-10 | Daebong Ls, Ltd. | 5-(4-hydroxybenzyl)thiazolidine-2,4-dione as intermediate for synthesis of thiazolidinedione based compounds and process for preparing the same |
| KR20120107493A (ko) | 2009-12-15 | 2012-10-02 | 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 | 대사성 질환의 치료를 위한 ｐｐａｒ 절약형 티아졸리딘디온염 |
| CN108003090A (zh) * | 2018-01-05 | 2018-05-08 | 白银亿尔精细化工有限公司 | 一种制备4-[2-(5-乙基-2-吡啶基)乙氧基]硝基苯的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57209274A (en) * | 1981-06-16 | 1982-12-22 | Takeda Chem Ind Ltd | Urea derivative, its preparation and its use |
| WO1986006069A1 (fr) * | 1985-04-09 | 1986-10-23 | Takeda Chemical Industries, Ltd. | Derives de thiazolidinedione, leur procede de preparation et composition medicinale les contenant |
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| JPS62205054A (ja) * | 1986-03-05 | 1987-09-09 | Takeda Chem Ind Ltd | 尿素誘導体 |
| US5952509A (en) * | 1996-06-27 | 1999-09-14 | Takeda Chemical Industries, Ltd. | Production of benzaldehyde compounds |
| JP4316787B2 (ja) * | 2000-01-11 | 2009-08-19 | 壽製薬株式会社 | エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、 |
-
2002
- 2002-04-25 US US10/475,099 patent/US7009057B2/en not_active Expired - Fee Related
- 2002-04-25 EP EP02734989A patent/EP1387843B1/de not_active Expired - Lifetime
- 2002-04-25 EE EEP200300519A patent/EE200300519A/xx unknown
- 2002-04-25 DE DE60218449T patent/DE60218449D1/de not_active Expired - Lifetime
- 2002-04-25 AT AT02734989T patent/ATE355286T1/de not_active IP Right Cessation
- 2002-04-25 SK SK1445-2003A patent/SK14452003A3/sk unknown
- 2002-04-25 RU RU2003134542/04A patent/RU2281285C2/ru not_active IP Right Cessation
- 2002-04-25 AU AU2002311057A patent/AU2002311057A1/en not_active Abandoned
- 2002-04-25 HU HU0400091A patent/HUP0400091A2/hu unknown
- 2002-04-25 WO PCT/CZ2002/000024 patent/WO2002088120A1/en not_active Ceased
- 2002-04-25 PL PL02363738A patent/PL363738A1/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002088120A1 (en) | 2002-11-07 |
| RU2003134542A (ru) | 2005-06-10 |
| DE60218449D1 (de) | 2007-04-12 |
| SK14452003A3 (sk) | 2004-04-06 |
| PL363738A1 (en) | 2004-11-29 |
| EE200300519A (et) | 2004-02-16 |
| US7009057B2 (en) | 2006-03-07 |
| WO2002088120B1 (en) | 2004-02-26 |
| US20050043360A1 (en) | 2005-02-24 |
| RU2281285C2 (ru) | 2006-08-10 |
| EP1387843A1 (de) | 2004-02-11 |
| EP1387843B1 (de) | 2007-02-28 |
| AU2002311057A1 (en) | 2002-11-11 |
| HUP0400091A2 (hu) | 2004-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE355286T1 (de) | Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel | |
| ATE348814T1 (de) | Verfahren zur herstellung von chinolinderivaten | |
| EA200200481A1 (ru) | Способ получения производных 4-трифторметилсульфинилпиразола | |
| ATE261946T1 (de) | Verfahren zur herstellung von thiazolidin | |
| DE69814608D1 (de) | Verfahren zur herstellung von 2-thienylamin-derivaten | |
| ATE442363T1 (de) | Verfahren zur herstellung von pyridinverbindungen | |
| ATE373071T1 (de) | Zusammensetzung und verfahren zur behandlung von halbleitersubstraten | |
| ATE272637T1 (de) | Verfahren zur herstellung einer substituierten imidazopyridinverbindung | |
| DE50100698D1 (de) | Verfahren zur Herstellung von 1,3,6-Hexantricarbonitril | |
| ATE419230T1 (de) | Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin | |
| DE59712632D1 (de) | Verfahren zur herstellung von 3-pyrrolin-2-carbonsäure-derivaten | |
| BR0015163A (pt) | Substrato enzimático, processo de sìntese de um substrato enzimático, composição e processo para a detecção e/ou a identificação e/ou a quantificação de pelo menos um microorganismo, kit de diagnóstico e utilização de um substrato enzimático | |
| ATE380171T1 (de) | Verfahren zur herstellung von terbinafine | |
| ATE528358T1 (de) | Verfahren zur herstellung einer azoverbindung | |
| ATE260239T1 (de) | Verfahren zur herstellung eines aminoalkohol | |
| ATE240945T1 (de) | Verfahren zur herstellung von 4-((2',5'-diamino- 6'-halogenpyrimidin-4'-yl)amino)-cyclopent-2- enylmethanolen | |
| DE60125386D1 (de) | Verfahren zur Prävention einer durch Gefrieren induzierten Abnahme der Aktivität eines Proteins | |
| ATE251616T1 (de) | Verfahren zur herstellung von 5- hydroxymethylthiazole | |
| EP1650195A4 (de) | Verfahren zur inhibierung der produktion von osteopontin | |
| ATE286881T1 (de) | Verfahren zur zyklisierung von optisch aktiven 4- amino-2-halogenbuttersäuren | |
| WO2002100804A3 (en) | Novel use of sulfamic acids as resolving agent. | |
| DE60222475D1 (de) | Poly-beta-carbonsäureacrylamid polymer, seine verwendung und verfahren zu seiner herstellung | |
| DE60028998D1 (de) | Verfahren zur herstellung einer benzylamin-verbindung | |
| EP1035125A3 (de) | 2-Pyridylsilan, Verfahren zur deren Herstellung und Verwendung | |
| DE60306506D1 (de) | Verfahren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |